Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: Preliminary results

M. B. Chancellor, A. Atan, D. A. Rivas, Toyohiko Watanabe, H. L. Tai, H. Kumon

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The aim of this study was to determine the efficacy of intranasal desmopressin in the treatment of nocturnal polyuria in men with benign prostatic hyperplasia (BPH). Twelve men with BPH were treated with intranasal desmopressin at bedtime for nocturnal polyuria. All patients underwent video- urodynamic evaluation. The number of nocturia episodes was the dependent variable. Exclusion criteria included nephrolithiasis, active urinary tact infection, and history of myocardial infarction, congestive heart failure, and angina. Ten of 12 patients improved with the intranasal desmopressin therapy. Nocturia episodes decreased from a median of 3.6 ± 0.5 episodes/night before treatment to 1.8 ± 1.1 episodes/night 3 months after therapy (p = .01). The American Urological Association symptom index decreased from 19 ± 6 before treatment to 12 ± 6 after therapy (p = .02). Hyponatremia did not occur. We conclude that intranasal desmopressin is a promising therapy for nocturnal polyuria in selected BPH patients.

Original languageEnglish
Pages (from-to)191-194
Number of pages4
JournalTechniques in Urology
Volume5
Issue number4
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Nocturia
Deamino Arginine Vasopressin
Prostatic Hyperplasia
Polyuria
Therapeutics
Nephrolithiasis
Hyponatremia
Urodynamics
Heart Failure
Myocardial Infarction
Infection

Keywords

  • Benign prostate hyperplasia
  • Bladder
  • Desmopressin
  • Urodynamics
  • Vasopressin

ASJC Scopus subject areas

  • Urology

Cite this

Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia : Preliminary results. / Chancellor, M. B.; Atan, A.; Rivas, D. A.; Watanabe, Toyohiko; Tai, H. L.; Kumon, H.

In: Techniques in Urology, Vol. 5, No. 4, 1999, p. 191-194.

Research output: Contribution to journalArticle

Chancellor, M. B. ; Atan, A. ; Rivas, D. A. ; Watanabe, Toyohiko ; Tai, H. L. ; Kumon, H. / Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia : Preliminary results. In: Techniques in Urology. 1999 ; Vol. 5, No. 4. pp. 191-194.
@article{a7de18e7b1114218a6fb0712960a68e2,
title = "Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: Preliminary results",
abstract = "The aim of this study was to determine the efficacy of intranasal desmopressin in the treatment of nocturnal polyuria in men with benign prostatic hyperplasia (BPH). Twelve men with BPH were treated with intranasal desmopressin at bedtime for nocturnal polyuria. All patients underwent video- urodynamic evaluation. The number of nocturia episodes was the dependent variable. Exclusion criteria included nephrolithiasis, active urinary tact infection, and history of myocardial infarction, congestive heart failure, and angina. Ten of 12 patients improved with the intranasal desmopressin therapy. Nocturia episodes decreased from a median of 3.6 ± 0.5 episodes/night before treatment to 1.8 ± 1.1 episodes/night 3 months after therapy (p = .01). The American Urological Association symptom index decreased from 19 ± 6 before treatment to 12 ± 6 after therapy (p = .02). Hyponatremia did not occur. We conclude that intranasal desmopressin is a promising therapy for nocturnal polyuria in selected BPH patients.",
keywords = "Benign prostate hyperplasia, Bladder, Desmopressin, Urodynamics, Vasopressin",
author = "Chancellor, {M. B.} and A. Atan and Rivas, {D. A.} and Toyohiko Watanabe and Tai, {H. L.} and H. Kumon",
year = "1999",
language = "English",
volume = "5",
pages = "191--194",
journal = "Techniques in Urology",
issn = "1079-3259",
publisher = "Raven Press",
number = "4",

}

TY - JOUR

T1 - Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia

T2 - Preliminary results

AU - Chancellor, M. B.

AU - Atan, A.

AU - Rivas, D. A.

AU - Watanabe, Toyohiko

AU - Tai, H. L.

AU - Kumon, H.

PY - 1999

Y1 - 1999

N2 - The aim of this study was to determine the efficacy of intranasal desmopressin in the treatment of nocturnal polyuria in men with benign prostatic hyperplasia (BPH). Twelve men with BPH were treated with intranasal desmopressin at bedtime for nocturnal polyuria. All patients underwent video- urodynamic evaluation. The number of nocturia episodes was the dependent variable. Exclusion criteria included nephrolithiasis, active urinary tact infection, and history of myocardial infarction, congestive heart failure, and angina. Ten of 12 patients improved with the intranasal desmopressin therapy. Nocturia episodes decreased from a median of 3.6 ± 0.5 episodes/night before treatment to 1.8 ± 1.1 episodes/night 3 months after therapy (p = .01). The American Urological Association symptom index decreased from 19 ± 6 before treatment to 12 ± 6 after therapy (p = .02). Hyponatremia did not occur. We conclude that intranasal desmopressin is a promising therapy for nocturnal polyuria in selected BPH patients.

AB - The aim of this study was to determine the efficacy of intranasal desmopressin in the treatment of nocturnal polyuria in men with benign prostatic hyperplasia (BPH). Twelve men with BPH were treated with intranasal desmopressin at bedtime for nocturnal polyuria. All patients underwent video- urodynamic evaluation. The number of nocturia episodes was the dependent variable. Exclusion criteria included nephrolithiasis, active urinary tact infection, and history of myocardial infarction, congestive heart failure, and angina. Ten of 12 patients improved with the intranasal desmopressin therapy. Nocturia episodes decreased from a median of 3.6 ± 0.5 episodes/night before treatment to 1.8 ± 1.1 episodes/night 3 months after therapy (p = .01). The American Urological Association symptom index decreased from 19 ± 6 before treatment to 12 ± 6 after therapy (p = .02). Hyponatremia did not occur. We conclude that intranasal desmopressin is a promising therapy for nocturnal polyuria in selected BPH patients.

KW - Benign prostate hyperplasia

KW - Bladder

KW - Desmopressin

KW - Urodynamics

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0032752419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032752419&partnerID=8YFLogxK

M3 - Article

C2 - 10591256

AN - SCOPUS:0032752419

VL - 5

SP - 191

EP - 194

JO - Techniques in Urology

JF - Techniques in Urology

SN - 1079-3259

IS - 4

ER -